Fox Sports: “We’ve had a really good year for ophthalmologists.”

Fox Sports (via Bleacher Report)On Sunday, the company announced a $100 million fund to support more ophthalmic research and development.

That’s just a few hundred thousand dollars more than the previous year.

The $100 billion fund will be available to institutions like Emory University, Emory College, and Emory Medical Center.

Ophthalmologist Chris Patek, who will oversee the fund, said in a statement: “Our research is fundamental to our profession, but also provides a foundation for a healthier world.

The NIH is dedicated to providing critical funding to support the most promising research and discovery in this field.

It is a great opportunity to build a better ophthalmoscope, which is a major component of our future vision.”

Patek added: “The NIH has been a crucial partner in our research efforts over the years, and we look forward to working together with them in the years ahead.”

The news comes on the heels of a similar announcement from Emory, where Patekin said that the NIH will fund more than $1 billion in research over the next decade, but he did not specify how much.

The fund will allow Emory to research the use of low-cost ophthalmia products to treat vision loss.

Oxygenation is also a big concern, as the lack of oxygen in the eyes can be fatal.

According to Patekins medical adviser, Dr. Jeffrey H. Cohen, “We don’t really know if this is a trend that we’re going to see in the near future, or if it’s going to be more of a trend in the future.”

Cohen said the NIH is working on ways to reduce oxygen levels and will be able to fund a trial that will evaluate a low-oxygen solution.